Search

Immunotherapy / Systemic Therapy

AHNS05

NEUTROPHIL TO LYMPHOCYTE RATIO AND PERIPHERAL BLOOD BIOMARKERS CORRELATE WITH OUTCOMES AMONG PATIENTS WITH RECURRENT METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA AND SALIVARY GLAND CANCER TREATED ON A PHASE II TRIAL OF PEMBROLIZUMAB AND VORINOSTAT

Immunotherapy / Systemic Therapy

Cassie Pan1; Qian (Vicky) Wu2; Jenna Voutsinas2; Jeffrey J Houlton1; Brittany Barber1; Neal Futran1; Renato G Martins3; Jonathan R Fromm4; Cristina P Rodriguez3

1Department of Otolaryngology, University of Washington, Seattle, WA; 2Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; 3Division of Oncology, Department of Medicine, University of Washington, Seattle, WA; 4Department of Laboratory Medicine, University of Washington, Seattle, WA


AHNS09

EFFECT OF PREOPERATIVE IMMUNOTHERAPY ON COMPLICATIONS AFTER HEAD AND NECK SURGERY

Immunotherapy / Systemic Therapy

Ramez Philips, MD; Angela Alnemri; Adam Luginbuhl, MD; David Cognetti, MD; Joseph Curry, MD

Thomas Jefferson University Hospitals